arrow
B

Beth Borowsky

novartis pharmaceuticals corp
H指数:24
被引数:4,603

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Insights into the human pharmacokinetics and metabolism of branaplam, a splicing modulator of a survival motor neuron-2 (SMN2) and huntingtin (HTT) pre-MRNAs, in infants and adults.

关于branaplam(一种生存运动神经元-2(SMN2)和亨廷顿蛋白(HTT)前mRNA剪接调节剂)在婴儿和成人中的人体药代动力学和代谢的见解。

2025-12-130
PRE
Reversibility of cognitive worsening observed with BACE inhibitor umibecestat in the Alzheimer's Prevention Initiative (API) Generation Studies
2024-09-250
OAAI
A PET-CT study on neuroinflammation in Huntington's disease patients participating in a randomized trial with laquinimod

参加拉喹莫德随机试验的亨廷顿病患者神经炎症的pet-ct研究

2023-04-0311
OAAI
An orally available, brain penetrant, small molecule lowers huntingtin levels by enhancing pseudoexon inclusion
2022-03-0363
OAAI
Safety and efficacy of pridopidine in patients with Huntington's disease (PRIDE-HD): a phase 2, randomised, placebo-controlled, multicentre, dose-ranging study
2019-02-0179
PREAI
COMPENSATION IN PRECLINICAL HUNTINGTON'S DISEASE: EVIDENCE FROM THE TRACK-ON HD STUDY
2016-09-130
PREAI
Compensation in Preclinical Huntington's Disease: Evidence From the Track-On HD Study

临床前亨廷顿舞蹈病的补偿: 来自跟踪HD研究的证据

2015-10-01103
OAAI